| Q2 2008 |
|
First Human Trial Complete |
|
InnerVision completes Breast Cancer and Carotid Artery segments of human trial. |
| Q1 2008 |
|
Commencement of Human Trials |
|
InnerVision commences its human trials for imaging Breast Cancer, Prostate Cancer and blocked Carotid Arteries. |
| Q4 2007 |
|
Final Approvals for Clinical Trials |
|
InnerVision receives final approval to commence clinical trials. |
| Q2 2007 |
|
Clinical Prototype Completion |
|
Completion of clinical prototype to be used in human trials. |
| Q4 2006 |
|
InnerVision Recapitalization |
|
InnerVision lowers its number of shares outstanding from greater than 20 million down to approximately 7 million shares. |
| Q4 2005 |
|
National Research Council funds technical development of InnerVision's Flash Ultrasound™. |
|
In November, the National Research Council selected InnerVision to receive an
Industrial Research Assistance Program grant of $203,500 over the next nine months. The non-repayable grant
required extensive due diligence on the part of the National Research Council. The grant supports the final
technical development activities required to commercialize Flash Ultrasound™. |
| Q4 2005 |
|
National Research Council funds technical development of InnerVision's Flash Ultrasound™. |
|
In October, Alberta Ingenuity Fund awarded InnerVision funding of $110,000 over two years. This award supports the research efforts the area of tissue characterization and, ultimately, cancer diagnosis. |
| Q3 2005 |
|
InnerVision profiled as technology to watch for industry insiders |
|
AuntMinnie.com Editor In Chief, Brian Casey introduces InnerVision
as a promising new technology: "InnerVision Medical Technologies hopes its Flash Ultrasound™ will result in a quantum leap in ultrasound resolution that will propel the
modality into new applications. Due to Flash Ultrasound™'s origins in technology used to
detect oil fields through bedrock, it holds promise for the visualization of hard structures
such as bone and microcalcifications in breast tissue.
|
| Q3 2005 |
|
International and U.S. Patent filed |
|
InnerVision filed a patent application titled Determining Attributes
Using Ultrasound to the U.S. patent office and international Patent Cooperation Treaty on
September 20, 2004. The patent claims advanced capabilities for determining tissue attributes
using ultrasound energy. The U.S. based, IP and patent law firm, Knobbe Martens Olson & Bear
LLP are representing InnerVision. |
| Q2 2005 |
|
AHFMR Research News - Spring 2005: InnerVision profiled as pioneer of faster, more accurate imaging technology |
|
InnerVision filed a patent application titled Determining Attributes
Using Ultrasound to the U.S. patent office and international Patent Cooperation Treaty on
September 20, 2004. The patent claims advanced capabilities for determining tissue attributes
using ultrasound energy. The U.S. based, IP and patent law firm, Knobbe Martens Olson & Bear
LLP are representing InnerVision. |
| Q1 2005 |
|
International Patent filed |
|
InnerVision filed an international patent application titled Systems and Methods for Improving
Imaging with the international Patent Cooperation Treaty on March 8, 2005. The patent claims a
resolution capability significantly greater than existing ultrasound technologies, and
proprietary techniques and algorithms that enable acoustic analysis beyond what acoustic
science has historically achieved. These same capabilities are included in the U.S. Patent
Application submitted by InnerVision in September 20, 2004, The U.S. based, IP and patent law
firm, Knobbe Martens Olson & Bear LLP are representing InnerVision. |
| Q4 2004 |
|
Initial Appointments to InnerVision Scientific Advisory Board |
|
InnerVision is pleased to announce the formation of and initial appointments to our
Scientific Advisory Board. Dr. Stuart Nicholson, M.D. and Dr. Michael Halliwell, Ph.D.
joined this board effective October 15, 2004. Dr. Nicholson is a diagnostic
radiologist with more than 30 years clinical experience and is widely published in
the area of fetal, maternal and cardiac ultrasound. Dr. Halliwell has spent the
last 40 years studying and advancing the field of medical ultrasound imaging. He
currently holds the position of Senior Research Fellow at the University of Bristol
Centre for Physics and Engineering in Medicine. Dr. Halliwell is widely published
and recognized internationally as both an expert and thought leader in ultrasound imaging. |
| Q3 2005 |
|
US Patent filed |
|
InnerVision filed a U.S Patent Application titled Systems and Methods for Improving Imaging
on September 20, 2004. The patent claims a resolution capability significantly greater than
existing ultrasound technologies, and proprietary techniques and algorithms that enable
acoustic analysis beyond what acoustic science has historically achieved. The U.S. based,
IP and patent law firm, Knobbe Martens Olson & Bear LLP are representing InnerVision. |
| Q3 2004 |
|
Alberta Heritage Fund for Medical Research |
|
InnerVision receives $500,000 in funding from the Government of Alberta |
Home
